From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes

被引:3
|
作者
Quiroga, Borja [1 ]
Ortiz, Alberto [2 ,3 ]
Navarro-Gonzalez, Juan F. [4 ,5 ,6 ,7 ]
Santamaria, Rafael [3 ,7 ,8 ]
de Sequera, Patricia [9 ]
Diez, Javier [10 ,11 ,12 ]
机构
[1] Hosp Univ la Princesa, Nephrol Dept, IIS La Princesa, Madrid, Spain
[2] Univ Autonoma Madrid, Fdn Jimenez Diaz, Dept Med, Div Nephrol IIS, Madrid, Spain
[3] Carlos III Inst Hlth, RICORS2040, Madrid, Spain
[4] Univ La Laguna, Univ Hosp Nuestra Senora de Candelaria, Div Nephrol, Santa Cruz De Tenerife, Spain
[5] Univ La Laguna, Univ Hosp Nuestra Senora de Candelaria, Res Unit, Santa Cruz De Tenerife, Spain
[6] Univ Inst Biomed Technol, Santa Cruz De Tenerife, Spain
[7] Univ Hosp Reina Sofia, Div Nephrol, Cordoba, Spain
[8] Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain
[9] Univ Complutense Madrid, Univ Hosp Infanta Leonor, Dept Nephrol, Madrid, Spain
[10] Univ Navarra, Ctr Appl Med Res, Pamplona, Spain
[11] Univ Navarra, Sch Med, Pamplona, Spain
[12] Carlos III Inst Hlth, Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain
关键词
acute kidney injury; cardionephrology; cardiorenal syndromes; chronic kidney disease; renocardiac syndromes; CHRONIC KIDNEY-DISEASE; TRIMETHYLAMINE-N-OXIDE; MILD RENAL-INSUFFICIENCY; CORONARY FLOW RESERVE; GROWTH-FACTOR; 23; HEART-FAILURE; CARDIOVASCULAR EVENTS; INFLAMMATORY CYTOKINES; PULMONARY-HYPERTENSION; SOLUBLE TWEAK;
D O I
10.1093/ckj/sfac113
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cardiorenal syndromes (CRS) are broadly defined as disorders of the heart and kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction of the other. CRS are currently classified into five categories, mostly based on disease-initiating events and their acuity or chronicity. CRS types 3 and 4 (also called renocardiac syndromes) refer to acute and chronic kidney dysfunction resulting in acute and chronic heart dysfunction, respectively. The notion of renocardiac syndromes has broadened interest in kidney-heart interactions but uncertainty remains in the nephrological community's understanding of the clinical diversity, pathophysiological mechanisms and optimal management approaches of these syndromes. This triple challenge that renocardiac syndromes (and likely other cardiorenal syndromes) pose to the nephrologist can only be faced through a specific and demanding training plan to enhance his/her cardiological scientific knowledge and through an appropriate clinical environment to develop his/her cardiological clinical skills. The first must be the objective of the subspecialty of cardionephrology (or nephrocardiology) and the second must be the result of collaboration with cardiologists (and other specialists) in cardiorenal care units. This review will first consider various aspects of the challenges that renocardiac syndromes pose to nephrologists and, then, will discuss those aspects of cardionephrology and cardiorenal units that can facilitate an effective response to the challenges.
引用
收藏
页码:19 / 29
页数:11
相关论文
共 50 条
  • [41] Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference
    House, Andrew A.
    Anand, Inder
    Bellomo, Rinaldo
    Cruz, Dinna
    Bobek, Ilona
    Anker, Stefan D.
    Aspromonte, Nadia
    Bagshaw, Sean
    Berl, Tomas
    Daliento, Luciano
    Davenport, Andrew
    Haapio, Mikko
    Hillege, Hans
    McCullough, Peter
    Katz, Nevin
    Maisel, Alan
    Mankad, Sunil
    Zanco, Pierluigi
    Mebazaa, Alexandre
    Palazzuoli, Alberto
    Ronco, Federico
    Shaw, Andrew
    Sheinfeld, Geoff
    Soni, Sachin
    Vescovo, Giorgio
    Zamperetti, Nereo
    Ponikowski, Piotr
    Ronco, Claudio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (05) : 1416 - 1420
  • [42] Cardiometabolic and cardiorenal syndromes interactions in Algerian diabetic-hypertensive patient: interest of predictive multi-biomarkers strategy to renal dysfunction
    Zoubiri, Houda
    Kacimi, Ghouti
    Haffaf, El Mahdi
    Oudjit, Brahim
    Adjroud, Naima
    Koceir, Elhadj-Ahmed
    ANNALES DE BIOLOGIE CLINIQUE, 2015, 73 (04) : 443 - 453
  • [43] ADQI 7: the clinical management of the Cardio-Renal syndromes: work group statements from the 7th ADQI consensus conference
    Davenport, A.
    Anker, S. D.
    Mebazaa, A.
    Palazzuoli, A.
    Vescovo, G.
    Bellomo, R.
    Ponikowski, P.
    Anand, I.
    Aspromonte, N.
    Bagshaw, S.
    Berl, T.
    Bobek, I.
    Cruz, D. N.
    Daliento, L.
    Haapio, M.
    Hillege, H.
    House, A.
    Katz, N.
    Maisel, A.
    Mankad, S.
    McCullough, P.
    Ronco, F.
    Shaw, A.
    Sheinfeld, G.
    Soni, S.
    Zamperetti, N.
    Zanco, P.
    Ronco, C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (07) : 2077 - 2089
  • [44] Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial
    Akerblom, Axel
    Clare, Robert M.
    Lokhnygina, Yuliya
    Wallentin, Lars
    Held, Claes
    Van de Werf, Frans
    Moliterno, David J.
    Patel, Uptal D.
    Leonardi, Sergio
    Armstrong, Paul W.
    Harrington, Robert A.
    White, Harvey D.
    Aylward, Philip E.
    Mahaffey, Kenneth W.
    Tricoci, Pierluigi
    AMERICAN HEART JOURNAL, 2016, 178 : 1 - 8
  • [45] Hyperglycemia in Acute Coronary Syndromes From Mechanisms to Prognostic Implications
    Kosiborod, Mikhail
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 185 - +
  • [46] Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes
    Papadopoulos, Vasileios
    Diamantopoulos, Panagiotis T.
    Papageorgiou, Sotirios G.
    Papoutselis, Menelaos
    Vrachiolias, George
    Pappa, Vassiliki
    Galanopoulos, Athanasios G.
    Vassilakopoulos, Theodoros P.
    Hatzimichael, Eleftheria
    Zikos, Panagiotis
    Papadaki, Helen A.
    Bouchla, Anthi
    Panayiotidis, Panayiotis
    Megalakaki, Aekaterini
    Papaioannou, Maria
    Liapis, Konstantinos
    Dryllis, George
    Tsokanas, Dimitris
    Kourakli, Alexandra
    Symeonidis, Argiris
    Viniou, Nora-Athina
    Kotsianidis, Ioannis
    HEMATOLOGICAL ONCOLOGY, 2020, 38 (04) : 541 - 553
  • [47] Quantification of Renal Function and Cardiovascular Mortality in Patients Admitted to the Emergency Department with Suspected Acute Coronary Syndromes: Results from the TRAPID-AMI Study
    Bahrmann, Philipp
    Bertsch, Thomas
    Giannitsis, Evangelos
    Christ, Michael
    Hofner, Benjamin
    Christenson, Robert
    Lindahl, Bertil
    Mueller, Christian
    CLINICAL LABORATORY, 2017, 63 (09) : 1457 - 1466
  • [48] Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum
    Kavanagh, David
    Ardissino, Gianluigi
    Brocklebank, Vicky
    Bouwmeester, Romy N.
    Bagga, Arvind
    ter Heine, Rob
    Johnson, Sally
    Licht, Christoph
    Ma, Alison L. T.
    Noris, Marina
    Praga, Manuel
    Rondeau, Eric
    Sinha, Aditi
    Smith, Richard J. H.
    Sheerin, Neil S.
    Trimarchi, H.
    Wetzels, Jack F. M.
    Vivarelli, Marina
    van de Kar, Nicole C. A. J.
    Greenbaum, Larry A.
    KIDNEY INTERNATIONAL, 2024, 106 (06) : 1038 - 1050
  • [49] Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study
    Akerblom, Axel
    Ericsson, Niclas
    Wallentin, Lars
    Siegbalm, Agneta
    Barratt, Bryan J.
    Becker, Richard C.
    Budaj, Andrzej
    Himmelmann, Anders
    Husted, Steen
    Storey, Robert F.
    Johansson, Asa
    James, Stefan K.
    AMERICAN HEART JOURNAL, 2014, 168 (01) : 96 - 102
  • [50] Ghrelin and cachexia: Will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?
    DeBoer, Mark D.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2011, 340 (01) : 97 - 105